Stock FAQs

how high will vxrt stock go

by Dolores Nienow Published 2 years ago Updated 2 years ago
image

14 Days Historical Data

Date Opening price Closing price Minimum price Maximum price
2022-03-11 Open: 4.790 Close: 4.460 Low: 4.460 High: 4.790
2022-03-10 Open: 4.650 Close: 4.790 Low: 4.580 High: 4.790
2022-03-09 Open: 4.600 Close: 4.760 Low: 4.580 High: 4.760
2022-03-08 Open: 4.260 Close: 4.380 Low: 4.175 High: 4.540
Apr 7 2022

Stock Price Forecast
The 4 analysts offering 12-month price forecasts for Vaxart Inc have a median target of 11.50, with a high estimate of 18.00 and a low estimate of 7.00. The median estimate represents a +260.50% increase from the last price of 3.19.

Full Answer

Will vxrt stock price hit 10 USD price in the future?

14 rows · Mar 28, 2022 · If you are looking for stocks with good return, Vaxart Inc stock can be a bad, high-risk ...

Is Vaxart's (vxrt) share price in a bullish cycle?

Apr 08, 2022 · Vaxart's stock was trading at $2.07 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, VXRT shares have increased by 72.0% and is now trading at $3.56. View which stocks have been most impacted by COVID-19.

Is vxrt a sell or buy on Robinhood?

May 10, 2022 · The Vaxart stock price gained 1.90% on the last trading day (Tuesday, 10th May 2022), rising from $3.16 to $3.22. During the day the stock fluctuated 13.92% from a day low at $2.91 to a day high of $3.32. The price has been going up and down for this period, and there has been a -10.8% loss for the last 2 weeks.

image

Will VXRT stock go up?

During the day the stock fluctuated 9.04% from a day low at $3.43 to a day high of $3.74. The price has fallen in 7 of the last 10 days and is down by -24.23% for this period.
...
Predicted Opening Price for Vaxart of Friday, April 29, 2022.
Fair opening price April 29, 2022Current price
$3.62$3.69 (Overvalued)

Is VXRT a good stock to buy now?

Vaxart has received a consensus rating of Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.

Will VXRT stock go up tomorrow?

Tomorrow's movement Prediction of Vaxart, Inc. VXRT as on 04 May 2022 appears strongly Bullish. This stock started moving upwards as soon as it opened.
...
Munafa value: 75 as on 04 Wed May 2022.
Upside target4.38
Upside target4.13
Downside target4.02
Downside target3.94
Downside target3.86
5 more rows

What will CRSP stock be worth in 2025?

CRISPR Therapeutics (CRSP -6.89%), a company leaning on gene-editing technology to precisely alter genomic DNA and tackle hard-to-treat diseases, is expected to see sales climb from $719,000 in 2020 to a consensus of $1.377 billion by 2025.Sep 30, 2021

Is VXRT a buy or sell?

Out of 4 analysts, 3 (75%) are recommending VXRT as a Strong Buy, 0 (0%) are recommending VXRT as a Buy, 1 (25%) are recommending VXRT as a Hold, 0 (0%) are recommending VXRT as a Sell, and 0 (0%) are recommending VXRT as a Strong Sell. What is VXRT's earnings growth forecast for 2022-2024?

Should I buy VXRT Zacks?

The Price to Earnings ratio or P/E is price divided by earnings.
...
Momentum Scorecard. More Info.
Zacks RankDefinitionAnnualized Return
1Strong Buy24.93%
2Buy18.44%
3Hold9.99%
4Sell5.61%
2 more rows

Is OCGN a buy?

CEPI will fund the researchers to conduct activities including immunogen design, preclinical studies, manufacturing process development and a Phase 1 clinical trial. Analyst Robert LeBoyer from Noble Financial reiterated a Buy rating on Ocugen (OCGN), with a $15 price target.

Is BNGO a good investment?

Speaking of revenue, this company is sizzling, though it isn't profitable yet. Its annual revenue has grown by 77.5% in the last three years, and sales in 2021 clocked in at nearly $18 million, a rise of 111% year over year.Mar 19, 2022

How high will DKNG stock go?

Stock Price Forecast

The 26 analysts offering 12-month price forecasts for DraftKings Inc have a median target of 25.00, with a high estimate of 60.00 and a low estimate of 16.00. The median estimate represents a +120.26% increase from the last price of 11.35.

Will Nvta stock go up?

Invitae Corp (NYSE:NVTA)

The 8 analysts offering 12-month price forecasts for Invitae Corp have a median target of 14.50, with a high estimate of 31.75 and a low estimate of 7.00. The median estimate represents a +189.42% increase from the last price of 5.01.

Why did Crispr stock drop?

CRISPR Therapeutics (CRSP -8.83%) stock sank by 15.9% in January, according to data from S&P Global Market Intelligence, amid a surge of bearish momentum impacting the broader market. An assortment of risk factors last month led investors to sell stocks lower.Feb 8, 2022

"Should I invest in Vaxart stock?" "Should I trade "VXRT" stock today?"

According to our live Forecast System, Vaxart Inc stock is a bad long-term (1-year) investment *.

What is the Vaxart stock price / share price today?

The Vaxart stock price is 4.240 USD today.

Will VXRT stock price drop / fall?

Yes. The Vaxart stock price may drop from 4.240 USD to 4.235 USD...

Will VXRT stock price grow / rise / go up?

No. See above .

Will VXRT stock price crash?

According to our analysis, this can happen.

Will Vaxart stock price hit 10 USD price in a year?

Not within a year. See above .

Will Vaxart stock price hit 20 USD price in a year?

Not within a year. See above .

Will Vaxart stock price hit 50 USD price in a year?

Not within a year. See above .

Is Vaxart a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Vaxart in the last year. There are currently 1 hold rati...

How has Vaxart's stock price been impacted by COVID-19?

Vaxart's stock was trading at $2.07 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since the...

When is Vaxart's next earnings date?

Vaxart is scheduled to release its next quarterly earnings announcement on Monday, May 2nd 2022. View our earnings forecast for Vaxart .

How were Vaxart's earnings last quarter?

Vaxart, Inc. (NASDAQ:VXRT) issued its quarterly earnings data on Thursday, February, 24th. The biotechnology company reported ($0.17) earnings per...

When did Vaxart's stock split? How did Vaxart's stock split work?

Vaxart shares reverse split on the morning of Wednesday, February 14th 2018. The 1-11 reverse split was announced on Tuesday, February 13th 2018. T...

What price target have analysts set for VXRT?

4 brokerages have issued 12-month price targets for Vaxart's shares. Their forecasts range from $9.00 to $18.00. On average, they expect Vaxart's s...

Who are Vaxart's key executives?

Vaxart's management team includes the following people: Andrei Floroiu , President CEO, CFO & Director Sean N. Tucker , Chief Scientific Officer...

Who are some of Vaxart's key competitors?

Some companies that are related to Vaxart include ImmunityBio (IBRX) , Twist Bioscience (TWST) , Bavarian Nordic A/S (BVNRY) , Iovance Biothera...

What other stocks do shareholders of Vaxart own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vaxart investors own include Inovio Pharmaceuticals (INO)...

Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Vaxart stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock.

Support, Risk & Stop-loss

Vaxart finds support from accumulated volume at $4.30 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

Is Vaxart stock A Buy?

Vaxart holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Insiders are negative selling more shares than they are buying in Vaxart

In the last 100 trades there were 26.13 million shares bought and 53.77 million shares sold. The last trade was done 10 days ago by Berg Edward B who bough 285 thousand shares. In general the insiders are selling more stocks than they buy. There can be a variety of reasons for this, but in general it can be considered as a negative signal.

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

VXRT : Vaxart stock forecast by Wall Street Analysts

Also, this average forecast of $15.0 represents a 12.53% increase from the past average forecast of $13.33, 6 months ago from 3 wall street analysts.

Frequently Asked Questions about Vaxart stock forecast

From Vaxart stock forecast , Vaxart (VXRT) stock cannot be a good investment choice. According to AI Pickup, the Vaxart stock price forecast for 2022 Mar. is $4.66761847653636

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9